Citation: Nikodem J. Poplawski, Abbas Shirinifard, Maciej Swat, James A. Glazier. Simulation of single-species bacterial-biofilm growth using the Glazier-Graner-Hogeweg model and the CompuCell3D modeling environment[J]. Mathematical Biosciences and Engineering, 2008, 5(2): 355-388. doi: 10.3934/mbe.2008.5.355
Health Impact Assessment (HIA) was first defined in 1999 as “A combination of procedures, methods and tools by which a policy, programme or project may be judged as to its potential effects on the health of a population and the distribution of those effects within the population” [1]. The methodology is underpinned by the ubiquitous socioeconomic model of health shown in Figure 1, also commonly known as the “rainbow model” illustrating the wider determinants of health [2].
Source: Dahlgren and Whitehead (1991). Policies and strategies to promote social equity in health.
Stockholm: Institute of Future Studies
The two main roots of HIA methodology were and continue to be firstly, response to concerns about hazardous environmental events affecting population health (examined through the lens of Environmental Assessment methods) and secondly, public health and health promotion disciplines that seek to develop healthy public policies globally, to protect and improve population health and well-being and reduce health inequalities or disparities (through the lens of HIA). HIA and all its?various iterations, such as those focussing on equity and mental well-being, continues to be advocated globally as a tool for the effective implementation of Health in All Policies [3], a World Health Organisation (WHO) initiative intended to support the development of healthy public policies, providing a tangible way for partners (at all levels and across organisations and sectors) to actually work together rather than just talking about working together [4].
The emergence of these two separate disciplines in parallel, each in their various formats and iterations, each founded upon (different) sound and robust scientific evidence bases has resulted in overlaps in methodology, but in practice and implementation, few links between them [5]. Nor has the emergence of separate nomenclatures and terminologies assisted in encouraging a closer and now ever more pressing need globally and nationally for shared understanding and joint, efficient, working in seeking to address prescient matters such as global warming, climate change, energy and infrastructure sustainability, preparedness for emergency and disastrous events, in combination with the demands of an increasing and ageing population and against a background of austerity measures in all sectors.
For example, discussing at some length the connotations of language used in the two disciplines, particularly the word risk (bringing the notion of hazard related usually to a substance and thus inferring the possibility of quantifying the probability of exposure and severity of consequences), it has been noted that while risk assessments can indeed be descriptive and qualitative, this is not always helpful to lovers of quantitative data (and consequently those who seek to monetise the estimates made in their analysis)[6]. Impact assessments are aimed at structuring and supporting the development of “better” (ie of greater public benefit, particularly for those with least equity in society) policies, plans, projects and programmes relative to the wider determinants of health (Figure 1). The credibility of risk assessment can therefore be challenged as being unnecessarily complex and not well connected in reality to the needs and demands of decision making processes. Additionally, the lack of stakeholder involvement and participation in risk assessment (a characteristic of most HIAs) is a pitfall that reduces reliability and transparency of outputs; it needs to relate to the needs of decision makers earlier and be more holistic than cause and effect; the level of detail needs to be adjusted to decision making needs and in an era of civic engagement, co-design, co-production, community resilience, etc, it needs stakeholder participation (rather than merely statutory consultation or engagement processes) at all stages.
There are many methodological iterations of HIA available in the literature, covering a wide continuum of practice [7], previously described as ranging from “tight” risk reduction approaches based upon a bio-medical model of health to “broad” approaches, based upon the wider determinants of health model[8]. A recent iteration of HIA methodology (Figure 2) was developed to better link routinely available summary population statistics to policy and decision makers in a timely and meaningful way through the shared participative HIA experience [7].
Source: Dreaves H, Pennington A, Scott-Samuel A (2015) Urban Health Impact Assessment methodology (UrHIA). Liverpool: IMPACT, University of Liverpool. http://www.liv.ac.uk/media/livacuk/instituteofpsychology/Urban_HIA_guide_2015.pdf
The pressing need to bring a greater shared understanding of the evidence bases available to the now very separate impact assessment disciplines is perhaps best illustrated by consideration of the potential health impacts of air pollution, both ambient and household, relative to regulatory requirements. In the environmental assessment paradigm, projects and proposed developments are assessed in very considerable detail with regard to only the potential negative effects of (along with other matters) the statutory nuisances of air, noise and water, within the statutory requirements of an EU Directive on Environmental Impact Assessment (EIA). From the assessment, mitigation measures are proposed for achievement of compliance, consent or approval, i.e. the avoidance of legal infringement and consequent financial penalties, with management plans devised for their implementation. Statutory legislation requires air pollution monitoring of particulate matter (PM) of different sizes, i.e. slightly larger particles (PM 10) and slightly smaller particles (PM 2.5) found in the air [7]. Routine monitoring at PM 2.5 is yet to be wholly implemented in all EU countries. In UK local authorities, further complexity comes from a focus on nitrous oxides monitoring for environmental protection requirements by their environmental health departments, while their public health teams focus on PM 2.5 as required in the latest public health outcomes framework. Provided the project or proposed development meets these requirements, all is regarded as “well” and planning approval or consent processes may proceed. “right” biomedical HIAs would closely ally with the risk reduction approach and not seek to consider the wider determinants of health, the differential distribution of potential effects, any potential positive impacts, the reduction of health inequalities, strengthening of stakeholder equity in decision making, or any other potential effects, beyond those pertaining to legal requirements.
Further updating of the EU EIA Directive (now 2014/52/EU), accepted this year and for full implementation by 2017, often adhered to internationally as good practice, requires strengthening of the consideration of health in EIA[10], moving the wider determinants HIA paradigm back into close proximity with commercial EIA practice, bringing to bear the weight of “health” evidence on the known increase in risk and susceptibility of vulnerable population subgroups, such as women and young children, to the potential effects of smaller PMs, down to the smallest nanoparticles. In future and in light of the recent World Health Assembly May 2015 resolution on air pollution [11?/span>13], will it be sufficient in future to pass over the known positive health impacts of reductions in all forms of air pollution for these groups and the known interventions to reduce exposure, if a project or development proposal simply “comes in under the threshold” of air pollution monitoring as it currently stands? Shall environmental assessments (EA), formerly regarded as “passing muster” be regarded as adequate in future if they do not take account of the best public health science? What are the implications, not just for HIA, but impact assessment practice and planning consent processes globally at both national infrastructure and local levels and ultimately, of course, for the health and wellbeing of future generations?
It has been clear since the inception of the methodology that robust, quality assured HIA, with stakeholder participation, demands a broad range of “people” skills and competencies, alongside skills such as epidemiology and statistics. Resources have never been sufficient in either health or non-health contexts, to promote carrying out detailed HIAs on every policy, project, programme, or plan—this was never the intended use of HIA. Capacity building [14] and transfer of expertise in HIA is promoted across all sectors as a means of broadening understanding of the wider determinants of health and health inequalities /disparities across the globe. There is recent evidence from Europe [15] that capacity building and training to further consideration of health in all impact assessments continue to be identified as the most important facilitators, while conversely, lack of resources and capacity building and training are barriers to it. Even in those countries with legislation for HIA, there remains a “capacity and capability premium” creating perhaps a void in good governance and quality assurance and opportunities for the furtherment of less than robust HIA practice, something that might bring challenges to the methodology and its? practice.
There are, of course, several ways of addressing such a “void” Academic institutions should seek to offer appropriate modules at both under and postgraduate levels in accredited cross-curricular programmes, where credits gained may be transferable for future professional portfolio development. Such modules and courses ought also to be accessible to practicing professionals as non-credit bearing continuing education and part of their professional development (and performance review, perhaps). This will however take some time to work through into professional and commercial practice which as ever, continues to be at the mercy of organisational churn, political will and resource constraints. By definition, HIA is intended to be (ideally) upstream, ex ante and prospective, a decision support tool to influence decision makers and making. HIA is necessarily imperfect; it does not validate a scientific hypothesis; it certainly is not concerned with producing reports that have no function in reality, or the production of which becomes an end in itself; that HIA cannot be tested for its?accuracy in the scientific sense; nor can it “protect” commissioners from the challenge that any proposal has damaged health; that HIA is based upon an interpretive approach to science and that it is not about stopping proposals (however inappropriate)[16].
In the shorter term, then and bearing in mind that HIA is not an “expert-driven” methodology, but something that stakeholders are well able to utilise themselves, such as in community led HIAs, greater emphasis should be placed on routine, systematic HIA activity, embedding HIA culture into organisations ethos and practice. Where time and resources are of the essence, both to “do” HIA and to critically appraise reports received, routine HIA screening using validated tools or instruments specifically designed for the purpose, lends itself to evidencing (especially when placed in the public domain) that decision makers and stakeholders have indeed considered at that point in time any potential impacts on health and well-being, inequalities and equity of vulnerable sub-groups in decision making.
Where there are easily accessible, robust summaries of “what works” and for whom, i.e. the public health science evidence base on interventions and programmes, health determinants and health outcomes well studied and understood (and indeed those emerging, or re-emerging, as societies and our environment inexorably change) it would indeed be inappropriate, inefficient and wasteful to comprehensively interrogate the literature, particularly primary literature, for the purposes of HIA and informing decision makers, every single time, merely to “tick a bureaucratic box” Better perhaps to systematically consider, the recommendations of earlier HIAs, the summary evidence gathered for them and share with colleagues and stakeholders a mutual understanding of how best the evidence can be translated into recommendations for the short, medium and longer term benefit of the population under consideration, as and when resources allow.
In conclusion, a wider use of HIA methodology, to provide a “neutral” platform for linking research findings and best evidence to policy and decision makers and making in operational settings could be a means of for example, screening research bids to strengthen their impact statement (by seeking to suggest how the anticipated findings from pure research could contribute to improvement of health and well-being and reduce inequalities, etc). In a changing Higher Education environment, this may also encourage researchers to better identify potential intellectual property (IP) for future business development.
In practice, a political perception of “success” or lack of it, by public health professionals to achieve “closing the gap in a generation” (the strap line of the eponymous Marmot Review, i.e. WHO Commission on the Social Determinants of Health [17]) presents another timely opportunity [18] for HIA to be used to present to a new generation of policy and decision makers, known evidence from research and lessons learned from practice. Thus, systematic use of HIA presents an opportunity for them to make best use of public health science in support of evidence-based decision making, to avoid making some of the same mistakes as their predecessors.
The authors declare that they have no conflicts of interest in this article.
1. | Ovidiu Pârvu, David Gilbert, Monika Heiner, Fei Liu, Nigel Saunders, Simon Shaw, Spatial-Temporal Modelling and Analysis of Bacterial Colonies with Phase Variable Genes, 2015, 25, 1049-3301, 1, 10.1145/2742546 | |
2. | D. Rodriguez, B. Einarsson, A. Carpio, Biofilm growth on rugose surfaces, 2012, 86, 1539-3755, 10.1103/PhysRevE.86.061914 | |
3. | Séverine Urdy, On the evolution of morphogenetic models: mechano-chemical interactions and an integrated view of cell differentiation, growth, pattern formation and morphogenesis, 2012, 87, 14647931, 786, 10.1111/j.1469-185X.2012.00221.x | |
4. | Xing Jin, Jeffrey S. Marshall, Robert Nerenberg, Mechanics of biofilms formed of bacteria with fimbriae appendages, 2020, 15, 1932-6203, e0243280, 10.1371/journal.pone.0243280 | |
5. | Bruno Hay Mele, Francesco Giannino, Christian E. Vincenot, Stefano Mazzoleni, Fabrizio Cartení, Cell-Based Models in Plant Developmental Biology: Insights into Hybrid Approaches, 2015, 3, 2296-665X, 10.3389/fenvs.2015.00073 | |
6. | Pablo Gonzalez-de-Aledo, Andrey Vladimirov, Marco Manca, Jerry Baugh, Ryo Asai, Marcus Kaiser, Roman Bauer, An optimization approach for agent-based computational models of biological development, 2018, 121, 09659978, 262, 10.1016/j.advengsoft.2018.03.010 | |
7. | Susan D. Hester, Julio M. Belmonte, J. Scott Gens, Sherry G. Clendenon, James A. Glazier, Edmund J. Crampin, A Multi-cell, Multi-scale Model of Vertebrate Segmentation and Somite Formation, 2011, 7, 1553-7358, e1002155, 10.1371/journal.pcbi.1002155 | |
8. | C. Giverso, M. Scianna, L. Preziosi, N. Lo Buono, A. Funaro, Individual Cell-Based Model for In-Vitro Mesothelial Invasion of Ovarian Cancer, 2010, 5, 0973-5348, 203, 10.1051/mmnp/20105109 | |
9. | Marco Scianna, Luca Munaron, Multiscale model of tumor-derived capillary-like network formation, 2011, 6, 1556-181X, 597, 10.3934/nhm.2011.6.597 | |
10. | Tomas Storck, Cristian Picioreanu, Bernardino Virdis, Damien J. Batstone, Variable Cell Morphology Approach for Individual-Based Modeling of Microbial Communities, 2014, 106, 00063495, 2037, 10.1016/j.bpj.2014.03.015 | |
11. | Gaddiel Yonathan Ouaknin, Pinhas Zvi Bar-Yoseph, Stochastic Collective Movement of Cells and Fingering Morphology: No Maverick Cells, 2009, 97, 00063495, 1811, 10.1016/j.bpj.2009.05.064 | |
12. | Maciej H. Swat, Susan D. Hester, Ariel I. Balter, Randy W. Heiland, Benjamin L. Zaitlen, James A. Glazier, 2009, Chapter 13, 978-1-934115-64-0, 361, 10.1007/978-1-59745-525-1_13 | |
13. | Abbas Shirinifard, James Alexander Glazier, Maciej Swat, J. Scott Gens, Fereydoon Family, Yi Jiang, Hans E. Grossniklaus, Edmund J. Crampin, Adhesion Failures Determine the Pattern of Choroidal Neovascularization in the Eye: A Computer Simulation Study, 2012, 8, 1553-7358, e1002440, 10.1371/journal.pcbi.1002440 | |
14. | M. Scianna, L. Preziosi, Multiscale Developments of the Cellular Potts Model, 2012, 10, 1540-3459, 342, 10.1137/100812951 | |
15. | Z. Huang, E.S. McLamore, H.S. Chuang, W. Zhang, S. Wereley, J.L.C. Leon, M.K. Banks, Shear-induced detachment of biofilms from hollow fiber silicone membranes, 2013, 110, 00063592, 525, 10.1002/bit.24631 | |
16. | R. Allena, M. Scianna, L. Preziosi, A Cellular Potts Model of single cell migration in presence of durotaxis, 2016, 275, 00255564, 57, 10.1016/j.mbs.2016.02.011 | |
17. | Nikodem J. Popławski, Ubirajara Agero, J. Scott Gens, Maciej Swat, James A. Glazier, Alexander R. A. Anderson, Front Instabilities and Invasiveness of Simulated Avascular Tumors, 2009, 71, 0092-8240, 1189, 10.1007/s11538-009-9399-5 | |
18. | Xuefeng Gao, Chwanrow K. Baban, Mark Tangney, Sabin Tabirca, 2011, Computer simulation of hypoxia regulates avascular tumor growth through p27 expression, 978-1-4244-9323-4, 15, 10.1109/ICCME.2011.5876697 | |
19. | Abbas Shirinifard, J. Scott Gens, Benjamin L. Zaitlen, Nikodem J. Popławski, Maciej Swat, James A. Glazier, Neil A. Hotchin, 3D Multi-Cell Simulation of Tumor Growth and Angiogenesis, 2009, 4, 1932-6203, e7190, 10.1371/journal.pone.0007190 | |
20. | Marco Scianna, A Multiscale Hybrid Model for Pro-angiogenic Calcium Signals in a Vascular Endothelial Cell, 2012, 74, 0092-8240, 1253, 10.1007/s11538-011-9695-8 | |
21. | M.V. Sheraton, V.R. Melnikov, P.M.A. Sloot, Prediction and quantification of bacterial biofilm detachment using Glazier–Graner–Hogeweg method based model simulations, 2019, 482, 00225193, 109994, 10.1016/j.jtbi.2019.109994 | |
22. | Makiko Nonomura, Ying Xu, Study on Multicellular Systems Using a Phase Field Model, 2012, 7, 1932-6203, e33501, 10.1371/journal.pone.0033501 | |
23. | R. M. H. Merks, P. Koolwijk, Modeling Morphogenesisin silicoandin vitro: Towards Quantitative, Predictive, Cell-based Modeling, 2009, 4, 0973-5348, 149, 10.1051/mmnp/20094406 | |
24. | Filippo Castiglione, Emiliano Mancini, Marco Pedicini, Abdul Salam Jarrah, 2019, 9780128114322, 874, 10.1016/B978-0-12-809633-8.20454-8 | |
25. | M. V. Sheraton, J. K. H. Yam, C. H. Tan, H. S. Oh, E. Mancini, L. Yang, S. A. Rice, P. M. A. Sloot, Mesoscopic Energy Minimization Drives Pseudomonas aeruginosa Biofilm Morphologies and Consequent Stratification of Antibiotic Activity Based on Cell Metabolism , 2018, 62, 0066-4804, 10.1128/AAC.02544-17 | |
26. | Marco Scianna, Luca Munaron, Luigi Preziosi, A multiscale hybrid approach for vasculogenesis and related potential blocking therapies, 2011, 106, 00796107, 450, 10.1016/j.pbiomolbio.2011.01.004 | |
27. | Olaya Rendueles, Jean-Marc Ghigo, 2015, 9781683670919, 319, 10.1128/9781555817466.ch16 | |
28. | M. V. Sheraton, Peter M. A. Sloot, 2018, Chapter 38, 978-3-319-93697-0, 496, 10.1007/978-3-319-93698-7_38 | |
29. | J.A. Fozard, M. Lees, J.R. King, B.S. Logan, Inhibition of quorum sensing in a computational biofilm simulation, 2012, 109, 03032647, 105, 10.1016/j.biosystems.2012.02.002 | |
30. | Maciej H. Swat, Gilberto L. Thomas, Julio M. Belmonte, Abbas Shirinifard, Dimitrij Hmeljak, James A. Glazier, 2012, 110, 9780123884039, 325, 10.1016/B978-0-12-388403-9.00013-8 | |
31. | Nikodem J. Poplawski, Abbas Shirinifard, Ubirajara Agero, J. Scott Gens, Maciej Swat, James A. Glazier, Gustavo Stolovitzky, Front Instabilities and Invasiveness of Simulated 3D Avascular Tumors, 2010, 5, 1932-6203, e10641, 10.1371/journal.pone.0010641 | |
32. | Vivi Andasari, Ryan T. Roper, Maciej H. Swat, Mark A. J. Chaplain, Soheil S. Dadras, Integrating Intracellular Dynamics Using CompuCell3D and Bionetsolver: Applications to Multiscale Modelling of Cancer Cell Growth and Invasion, 2012, 7, 1932-6203, e33726, 10.1371/journal.pone.0033726 | |
33. | Julio M. Belmonte, Sherry G. Clendenon, Guilherme M. Oliveira, Maciej H. Swat, Evan V. Greene, Srividhya Jeyaraman, James A. Glazier, Robert L. Bacallao, Leah Edelstein-Keshet, Virtual-tissue computer simulations define the roles of cell adhesion and proliferation in the onset of kidney cystic disease, 2016, 27, 1059-1524, 3673, 10.1091/mbc.e16-01-0059 | |
34. | D. R. Espeso, A. Carpio, B. Einarsson, Differential growth of wrinkled biofilms, 2015, 91, 1539-3755, 10.1103/PhysRevE.91.022710 | |
35. | Olaya Rendueles, Jean-Marc Ghigo, Mahmoud Ghannoum, Matthew Parsek, Marvin Whiteley, Pranab Mukherjee, Mechanisms of Competition in Biofilm Communities, 2015, 3, 2165-0497, 10.1128/microbiolspec.MB-0009-2014 | |
36. | Hoa Nguyen, Abraham Ybarra, Hakan Başağaoğlu, Orrin Shindell, Biofilm viscoelasticity and nutrient source location control biofilm growth rate, migration rate, and morphology in shear flow, 2021, 11, 2045-2322, 10.1038/s41598-021-95542-1 | |
37. | Minggao Zheng, Qihua Liu, Yanyi Rao, UAV Based on Communication Network to Obtain Oil Pipeline Data and 3D Modeling, 2022, 2022, 1875-905X, 1, 10.1155/2022/6860631 | |
38. | Jinfeng Zhang, Yongqiang Tian, Jianglai Wang, Jinxiu Ma, Lu Liu, Rehmat Islam, Yonghong Qi, Jiajia Li, Tong Shen, Inhibitory effect and possible mechanism of oregano and clove essential oils against Pectobacterium carotovorum subsp. carotovorum as onion soft rot in storage, 2023, 196, 09255214, 112164, 10.1016/j.postharvbio.2022.112164 | |
39. | Andre Then, Jan Ewald, Natalie Söllner, Rebecca E. Cooper, Kirsten Küsel, Bashar Ibrahim, Stefan Schuster, Agent-based modelling of iron cycling bacteria provides a framework for testing alternative environmental conditions and modes of action, 2022, 9, 2054-5703, 10.1098/rsos.211553 | |
40. | Christian T. Michael, Sayed Ahmad Almohri, Jennifer J. Linderman, Denise E. Kirschner, A framework for multi-scale intervention modeling: virtual cohorts, virtual clinical trials, and model-to-model comparisons, 2024, 3, 2674-0702, 10.3389/fsysb.2023.1283341 | |
41. | Zhongyu Yan, Jingjie Yeo, Competing mechanisms in bacterial invasion of human colon mucus probed with agent-based modeling, 2024, 00063495, 10.1016/j.bpj.2024.05.028 | |
42. | Filippo Castiglione, Emiliano Mancini, Marco Pedicini, Abdul S. Jarrah, 2024, 9780128096338, 10.1016/B978-0-323-95502-7.00029-4 | |
43. | Tavishi Dutt, Jimpi Langthasa, Monica Umesh, Satyarthi Mishra, Siddharth Bothra, Kottpalli Vidhipriya, Annapurna Vadaparty, Prosenjit Sen, Ramray Bhat, Rheological transition driven by matrix makes cancer spheroids resilient under confinement, 2025, 8, 2575-1077, e202402601, 10.26508/lsa.202402601 | |
44. | Yumeng Fu, Jiankun Wang, Xiaoling Wang, Simulation of head-tail biofilm streamer growth based on immersed boundary method, 2025, 0892-7014, 1, 10.1080/08927014.2025.2490748 |